TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1150-1157

  Rubnitz, J E ^a   Downing, J R ^a   Pui, C H ^a   Shurtleff, S A ^a   Raimondi, S C ^a   Evans, W E ^a   Head, D R ^a   Crist, W M ^a   Rivera, G K ^a   Hancock, M L ^a   Boyett, J M ^a   Buijs, A ^a   Grosveld, G ^a   Behm, F G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CHROMOSOME TRANSLOCATION 12; FEMALE; GENE REARRANGEMENT; GENETIC MARKER; GERM LINE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031059356     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1150     Document Type: Article

References (36)

1. Rivera GK, Pinkel D, Simone JV, et al: Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 329:1289-1295, 1993
2. Pui C-H: Childhood leukemias. N Engl J Med 332:1618-1630, 1995
3. Pui C-H, Behm FG, Raimondi SC, et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 321:136-142, 1989
4. Pui C-H, Ribeiro RC, Hancock ML, et al: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682-1687, 1991
5. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
6. Steinherz PG, Gaynon PS, Breneman JC, et al: Cytoreduction and prognosis in acute lymphoblastic leukemia - The importance of early marrow response: Report from the Childrens Cancer Group. J Clin Oncol 14:389-398, 1996
7. Gajjar A, Ribeiro R, Hancock ML, et al: Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 86:1292-1295, 1995
8. Pui C-H, Crist WM: Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491-503, 1994
9. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18-24, 1996
10. Trueworthy R, Shuster J, Look T, et al: Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606-613, 1992
11. Rivera GK, Raimondi SC, Hancock ML, et al: Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61-66, 1991
12. Fletcher JA, Kimball VM, Lynch E, et al: Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 74:2130-2135, 1989
13. Crist W, Carroll A, Shuster J, et al: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489-494, 1990
14. Rubnitz JE, Link MP, Shuster JJ, et al: Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 84:570-573, 1994
15. Privitera E, Kamps MP, Hayashi Y, et al: Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79:1781-1788, 1992
16. Rubnitz JE, Behm FG, Downing JR: 11q23 rearrangements in acute leukemia. Leukemia 10:74-82, 1996
17. Golub TR, Barker GF, Bohlander SK, et al: Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-4921, 1995
18. Romana SP, Mauchauffe M, Le Coniat M, et al: The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670, 1995
19. Romana SP, Poirel H, Leconiat M, et al: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269, 1995
20. Shurtleff SA, Bujis A, Behm FG, et al: TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989, 1995
21. Liang D-C, Chou T-B, Chen J-S, et al: High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991-993, 1996
22. Evans WE, Rodman J, Relling MV, et al: Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. Semin Hematol 28:15-21, 1991 (suppl 4)
23. Behm FG, Raimondi SC, Schell MJ, et al: Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood 79:1011-1016, 1992
24. Williams DL, Harris A, Williams KJ, et al: A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 13:239-257, 1984
25. Pui C-H, Behm FG, Downing JR, et al: 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 12:909-915, 1994
26. Rubinstein LV, Gail MH, Santer TJ: Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chron Dis 34:469-479, 1981
27. Fleming TR, Harrington DP, O'Brien PC: Designs for group sequential tests. Control Clin Trial 5:348-361, 1984
28. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat 53:457-481, 1958
29. StatXact 3 for Windows. Cambridge, MA, Cytel Software Corporation 1995
30. Early Breast Cancer Trialists' Collaborative Group: Treatment of Early Breast Cancer: Worldwide Evidence 1985-1990. New York, NY, Oxford University, 1990
31. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187-220, 1972
32. Behm FG, Raimondi SC, Frestedt JL, et al: Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 87:2870-2877, 1996
33. Hiebert SW, Sun W-H, Davis JN, et al: The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349-1355, 1996
34. Okuda T, van Deursen J, Hiebert SW, et al: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330, 1996
35. Synold TW, Relling MV, Boyett JM, et al: Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 94:1996-2001, 1994
36. Kumagai M, Manabe A, Pui C-H, et al: Stromal-supported culture of childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 97:755-760, 1996